Literature DB >> 22886058

Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals.

C M Lonchel1, P Melin, J Gangoué-Piéboji, M-C O Assoumou, R Boreux, P De Mol.   

Abstract

Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae have been described worldwide, but there are few reports on the carriage of these bacteria in Cameroon. In order to investigate the types of ESBLs and to analyse some risk factors associated with ESBL carriage, faecal samples were collected between 3 January and 3 April 2009 from hospitalised patients at Yaounde Central Hospital and at two hospitals in Ngaoundere, Cameroon. Enterobacterial isolates resistant to third-generation cephalosporins were screened for ESBL production using the double-disk synergy test. Polymerase chain reaction (PCR) and DNA sequencing were performed in order to find out the different types of ESBL genes in presumptive ESBL-positive isolates. During the study period, a total of 121 different patients were screened for ESBL carriage. The prevalence among these patients whose faecal samples were found to contain ESBL-producers was 55.3 % (67/121). According to a univariate analysis, hospitalisation during the previous year was found to be associated with ESBL carriage. Of the 71 bacteria isolated, Escherichia coli was predominant and represented 48 % of all isolates. ESBL characterisation revealed two types of ESBLs, CTX-M-15 (96 %) and SHV-12 (4 %). The present study emphasises the importance of screening for ESBLs in laboratories in African countries. The monitoring and detection of ESBL-producing bacteria are important in the setting up of appropriate treatment of patients and to ensure effective infection control efforts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886058     DOI: 10.1007/s10096-012-1717-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  48 in total

Review 1.  Extended-spectrum beta-lactamases: how big is the problem?

Authors:  J J Rahal
Journal:  Clin Microbiol Infect       Date:  2000-08       Impact factor: 8.067

2.  Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.

Authors:  R Colodner; W Rock; B Chazan; N Keller; N Guy; W Sakran; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

3.  First report of CTX-M-15 and CTX-M-3 beta-lactamases among clinical isolates of Enterobacteriaceae in Béjaia, Algeria.

Authors:  Abdelaziz Touati; Said Benallaoua; Dominique Forte; Janick Madoux; Lucien Brasme; Christophe de Champs
Journal:  Int J Antimicrob Agents       Date:  2006-04-18       Impact factor: 5.283

Review 4.  Detection of blaSHV, blaTEM and blaCTX-M antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko Academic Hospital.

Authors:  Marthie M Ehlers; Chrisna Veldsman; Eddy P Makgotlho; Michael G Dove; Anwar A Hoosen; Marleen M Kock
Journal:  FEMS Immunol Med Microbiol       Date:  2009-05-08

5.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

6.  Extended-spectrum beta-lactamases in clinical isolates of enterobacteria in Mexico.

Authors:  J Silva; C Aguilar; Z Becerra; F López-Antuñano; R García
Journal:  Microb Drug Resist       Date:  1999       Impact factor: 3.431

7.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

8.  Nationwide spread of clonally related CTX-M-15-producing multidrug-resistant Klebsiella pneumoniae strains in Hungary.

Authors:  I Damjanova; A Tóth; J Pászti; A Bauernfeind; M Füzi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 5.103

9.  CTX-M Enzymes: Origin and Diffusion.

Authors:  Rafael Cantón; José María González-Alba; Juan Carlos Galán
Journal:  Front Microbiol       Date:  2012-04-02       Impact factor: 5.640

10.  Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania.

Authors:  Faustine Ndugulile; Roland Jureen; Stig Harthug; Willy Urassa; Nina Langeland
Journal:  BMC Infect Dis       Date:  2005-10-15       Impact factor: 3.090

View more
  15 in total

Review 1.  Antibacterial resistance in sub-Saharan Africa: an underestimated emergency.

Authors:  Samuel Kariuki; Gordon Dougan
Journal:  Ann N Y Acad Sci       Date:  2014-03-14       Impact factor: 5.691

Review 2.  ESBL-producing Enterobacteriaceae in Africa - a non-systematic literature review of research published 2008-2012.

Authors:  Viktor Storberg
Journal:  Infect Ecol Epidemiol       Date:  2014-03-13

3.  High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso.

Authors:  Abdoul-Salam Ouedraogo; Mahamadou Sanou; Aimée Kissou; Soufiane Sanou; Hermann Solaré; Firmin Kaboré; Armel Poda; Salim Aberkane; Nicolas Bouzinbi; Idrissa Sano; Boubacar Nacro; Lassana Sangaré; Christian Carrière; Dominique Decré; Rasmata Ouégraogo; Hélène Jean-Pierre; Sylvain Godreuil
Journal:  BMC Infect Dis       Date:  2016-07-11       Impact factor: 3.090

4.  Prevalence and risk factors for CTX-M gram-negative bacteria in hospitalized patients at a tertiary care hospital in Kilimanjaro, Tanzania.

Authors:  Tolbert Sonda; Happiness Kumburu; Marco van Zwetselaar; Michael Alifrangis; Blandina T Mmbaga; Ole Lund; Frank M Aarestrup; Gibson Kibiki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-20       Impact factor: 3.267

5.  Trends of Antibacterial Resistance at the National Reference Laboratory in Cameroon: Comparison of the Situation between 2010 and 2017.

Authors:  M Massongo; L Ngando; E W Pefura Yone; Ariane NZouankeu; W Mbanzouen; M C Fonkoua; A Ngandjio; J Tchatchueng; D Barger; M C Tejiokem
Journal:  Biomed Res Int       Date:  2021-05-22       Impact factor: 3.411

6.  Incidence, pathogens and resistance patterns of nosocomial infections at a rural hospital in Gabon.

Authors:  Micha Scherbaum; Katrin Kösters; Raymund Egid Mürbeth; Ulysse Ateba Ngoa; Peter Gottfried Kremsner; Bertrand Lell; Abraham Alabi
Journal:  BMC Infect Dis       Date:  2014-03-04       Impact factor: 3.090

Review 7.  Meta-analysis of proportion estimates of Extended-Spectrum-Beta-Lactamase-producing Enterobacteriaceae in East Africa hospitals.

Authors:  Tolbert Sonda; Happiness Kumburu; Marco van Zwetselaar; Michael Alifrangis; Ole Lund; Gibson Kibiki; Frank M Aarestrup
Journal:  Antimicrob Resist Infect Control       Date:  2016-05-14       Impact factor: 4.887

8.  High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia.

Authors:  Kassu Desta; Yimtubezinash Woldeamanuel; Aklilu Azazh; Halima Mohammod; Dawit Desalegn; Damte Shimelis; Dereje Gulilat; Biruk Lamisso; Eyasu Makonnen; Alemayehu Worku; Kerstin Mannerqvist; Johan Struwe; Olov Aspevall; Eleni Aklillu
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

9.  High fecal carriage of extended Beta Lactamase producing Enterobacteriaceae among adult patients admitted in referral hospitals in Dar es Salaam, Tanzania.

Authors:  Upendo O Kibwana; Mtebe Majigo; Doreen Kamori; Joel Manyahi
Journal:  BMC Infect Dis       Date:  2020-07-31       Impact factor: 3.090

Review 10.  Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review.

Authors:  Bugwesa Z Katale; Gerald Misinzo; Stephen E Mshana; Harriet Chiyangi; Susana Campino; Taane G Clark; Liam Good; Mark M Rweyemamu; Mecky I Matee
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-06       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.